Literature DB >> 12162983

Functional benefit of Dupuytren's surgery.

R Sinha1, T R Cresswell, R Mason, I Chakrabarti.   

Abstract

The results of surgery for Dupuytren's disease were prospectively assessed to see if there is a correlation between hand function, the degree of deformity and the post-operative result. A total of 42 patients were followed-up for 6 months. The mean flexion deformity was 81 degrees pre-operatively and 32 degrees post-operatively. The mean Sollerman score improved from 71 (out of 80) pre-operatively to 77 post-operatively. There was a significant correlation between the degree of deformity and the Sollerman score, and also between the improvement in deformity after surgery, and the Sollerman score. We conclude that hand function is worsened by increasing deformity in Dupuytren's disease and improved by correction of the deformity.

Entities:  

Mesh:

Year:  2002        PMID: 12162983     DOI: 10.1054/jhsb.2002.0776

Source DB:  PubMed          Journal:  J Hand Surg Br        ISSN: 0266-7681


  4 in total

Review 1.  Management of Dupuytren's disease--clear advice for an elusive condition.

Authors:  A Bayat; D A McGrouther
Journal:  Ann R Coll Surg Engl       Date:  2006-01       Impact factor: 1.891

Review 2.  Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.

Authors:  Catherine Ball; Anna L Pratt; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2013-04-10       Impact factor: 2.362

3.  Outcome review on the percutaneous release of the proximal interphalangeal joint accessory collateral ligaments.

Authors:  Sonja Cerovac; John Stanley
Journal:  Orthop Rev (Pavia)       Date:  2009-10-10

Review 4.  What are we measuring? A critique of range of motion methods currently in use for Dupuytren's disease and recommendations for practice.

Authors:  Anna L Pratt; Catherine Ball
Journal:  BMC Musculoskelet Disord       Date:  2016-01-13       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.